These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23565368)
1. Thyromimetics: What does the future hold? Unnikrishnan AG; Baruah M; Kalra S Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S159-61. PubMed ID: 23565368 [TBL] [Abstract][Full Text] [Related]
2. Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport. Pedrelli M; Pramfalk C; Parini P World J Gastroenterol; 2010 Dec; 16(47):5958-64. PubMed ID: 21157972 [TBL] [Abstract][Full Text] [Related]
3. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. Saponaro F; Sestito S; Runfola M; Rapposelli S; Chiellini G Front Med (Lausanne); 2020; 7():331. PubMed ID: 32733906 [TBL] [Abstract][Full Text] [Related]
4. Sobetirome: the past, present and questions about the future. Lammel Lindemann J; Webb P Expert Opin Ther Targets; 2016; 20(2):145-9. PubMed ID: 26565124 [TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. Delitala AP; Delitala G; Sioni P; Fanciulli G Curr Med Res Opin; 2017 Nov; 33(11):1985-1993. PubMed ID: 28498022 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-Pituitary-Thyroid Axis Perturbations in Male Mice by CNS-Penetrating Thyromimetics. Ferrara SJ; Bourdette D; Scanlan TS Endocrinology; 2018 Jul; 159(7):2733-2740. PubMed ID: 29846550 [TBL] [Abstract][Full Text] [Related]
7. The localization of thyroid hormone receptor mRNAs in human bone. Abu EO; Horner A; Teti A; Chatterjee VK; Compston JE Thyroid; 2000 Apr; 10(4):287-93. PubMed ID: 10807056 [TBL] [Abstract][Full Text] [Related]
8. Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone. Dupré SM; Guissouma H; Flamant F; Seugnet I; Scanlan TS; Baxter JD; Samarut J; Demeneix BA; Becker N Endocrinology; 2004 May; 145(5):2337-45. PubMed ID: 14726446 [TBL] [Abstract][Full Text] [Related]
9. Expression pattern and ontogenesis of thyroid hormone receptor isoforms in the mouse heart. Stoykov I; Zandieh-Doulabi B; Moorman AF; Christoffels V; Wiersinga WM; Bakker O J Endocrinol; 2006 May; 189(2):231-45. PubMed ID: 16648291 [TBL] [Abstract][Full Text] [Related]
10. Role of thyroid receptor β in lipid metabolism. Pramfalk C; Pedrelli M; Parini P Biochim Biophys Acta; 2011 Aug; 1812(8):929-37. PubMed ID: 21194564 [TBL] [Abstract][Full Text] [Related]
12. A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2. Lee S; Young BM; Wan W; Chan IH; Privalsky ML Mol Endocrinol; 2011 Jul; 25(7):1111-25. PubMed ID: 21622532 [TBL] [Abstract][Full Text] [Related]
13. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function. Wan W; Farboud B; Privalsky ML Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373 [TBL] [Abstract][Full Text] [Related]
14. TR expression and function in human bone marrow stromal and osteoblast-like cells. Siddiqi A; Parsons MP; Lewis JL; Monson JP; Williams GR; Burrin JM J Clin Endocrinol Metab; 2002 Feb; 87(2):906-14. PubMed ID: 11836340 [TBL] [Abstract][Full Text] [Related]
15. Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues. Shahrara S; Drvota V; Sylvén C Biol Pharm Bull; 1999 Oct; 22(10):1027-33. PubMed ID: 10549850 [TBL] [Abstract][Full Text] [Related]
16. Sobetirome: a case history of bench-to-clinic drug discovery and development. Scanlan TS Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of thyroid hormone receptor isoforms is strikingly related to cardiac and skeletal muscle phenotype during postnatal development. White P; Dauncey MJ J Mol Endocrinol; 1999 Oct; 23(2):241-54. PubMed ID: 10514561 [TBL] [Abstract][Full Text] [Related]
18. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia. Tancevski I; Demetz E; Eller P Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):16-9. PubMed ID: 21208155 [TBL] [Abstract][Full Text] [Related]
19. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B N Engl J Med; 2010 Mar; 362(10):906-16. PubMed ID: 20220185 [TBL] [Abstract][Full Text] [Related]
20. Expression of thyroid hormone receptor isoforms down-regulated by thyroid hormone in human medulloblastoma cells. Monden T; Nakajima Y; Hashida T; Ishii S; Tomaru T; Shibusawa N; Hashimoto K; Satoh T; Yamada M; Mori M; Kasai K Endocr J; 2006 Apr; 53(2):181-7. PubMed ID: 16618975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]